Jones Financial Companies
CAPR icon

Jones Financial Companies’s Capricor Therapeutics CAPR Stock Holding History

Jones Financial Companies’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46K Hold
189
– – ﹤0.01% 3797
2025
Q4 		$5.46K Buy
189
+109
+136% +$1.42K ﹤0.01% 3461
2025
Q3 		$567 Sell
80
-1,916
-96% -$14.1K ﹤0.01% 4020
2025
Q2 		$22.3K Buy
1,996
+1,943
+3,666% +$20.5K ﹤0.01% 2544
2025
Q1 		$610 Buy
+53
New +$736 ﹤0.01% 3489

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jones Financial Companies's CAPR Position: Q1 2026 in Review

Jones Financial Companies held its Capricor Therapeutics (CAPR) position steady in Q1 2026 at 189 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3797.

Jones Financial Companies first reported a position in CAPR in Q1 2025 and has held it in 5 quarters since. The position peaked at $22.3K in Q2 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Jones Financial Companies held 189 shares of Capricor Therapeutics worth $5.46K as of Q1 2026.
  • Jones Financial Companies left its Capricor Therapeutics share count unchanged in Q1 2026.
  • Capricor Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3797 holding.
  • Jones Financial Companies first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Capricor Therapeutics position peaked at $22.3K in Q2 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.